Edition:
United States

bluebird bio Inc (BLUE.O)

BLUE.O on Nasdaq

103.43USD
18 Dec 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$103.43
Open
$105.62
Day's High
$105.62
Day's Low
$101.00
Volume
1,481,082
Avg. Vol
729,541
52-wk High
$236.17
52-wk Low
$99.15

Chart for

About

bluebird bio, Inc. is a clinical-stage biotechnology company. The Company is focused on developing gene therapies for severe diseases and cancer. With its lentiviral-based gene therapy and gene editing capabilities, it has built an integrated product platform with various applications in these areas. The Company's clinical... (more)

Overall

Beta: 2.03
Market Cap(Mil.): $5,824.04
Shares Outstanding(Mil.): 45.59
Dividend: --
Yield (%): --

Financials

  BLUE.O Industry Sector
P/E (TTM): -- 69.72 34.40
EPS (TTM): -7.36 -- --
ROI: -25.26 9.00 14.96
ROE: -29.40 10.14 16.53

Earnings vs. Estimates